• Stellantis is to book an impairment charge of 297 million euros in the first half of the year and enters into a framework agreement with Dongfeng paving the way for possible share buybacks.
  • The Boeing Company lowers its industry-wide demand forecast for aircraft over the next 20 years.
  • Elon Musk seeks to block Twitter's request for an expedited trial.
  • ASM International will  buy Italian epitaxy tool maker LPE for $429 million.
  • Gazprom asks Siemens Energy to submit documents related to the return of a repaired gas turbine to Canada.
  • Roche launches screening test for hepatitis C virus.
  • Holcim wins two EU grants for carbon capture and storage projects.
  • Frasers Group reportedly wants to get its hands on fast fashion site I Saw It First, which is owned by the co-founder of Boohoo Group.
  • Arcadis is buying Canadian technology group IBI for $672 million.
  • Nordea Bank exceeds expectations in the second quarter.
  • Solvay reports record second quarter results.
  • HSBC buys back $20 million worth of shares in London and Hong Kong as part of its $1 billion buyback plan.
  • Iberdrola's electricity production rose 2% in the second quarter.
  • Rolls-Royce will conduct engine tests to evaluate the potential of hydrogen jets.
  • EasyJet and Ryanair cancel flights from Italy due to an air traffic controller strike.
  • Bank of America reported Monday a decline in second-quarter profit, due to a drop in investment banking revenue.
  • Goldman Sachs gained 1.7 percent in premarket trading after reporting a smaller-than-expected decline in second-quarter profit.
  • Delta Air Lines announced Monday that it has ordered 100 of its 737 MAX 10 aircraft from Boeing for about $13.5 billion at list price and has placed an option for 30 more.
  • Starbucks is not engaged in a formal process to sell its U.K. business, a spokesman for the group said Saturday after the Times reported earlier that the coffee chain was exploring a potential sale.
  • Alphabet was up 1.8 percent in premarket trading on the eve of its first day of trading following a 20-for-1 stock split.
  • Abbott Laboratories said Friday it expects to market its EleCare baby powder produced at its Sturgis plant, which was recently reopened after being at the center of the U.S. infant milk shortage, in the coming weeks.
  • Biogen - Analysts at Wells Fargo said Biogen could beat second-quarter earnings expectations in its earnings call Wednesday, thanks to strong demand for its multiple sclerosis drugs.
  • Coinbase, which specializes in cryptoassets, announced on Monday that it had received the green light from Italian authorities to continue offering its services in Italy.

Main earnings reports today: Bank of America, International Business Machines, The Charles Schwab Corporation ... All the agenda here.